CME Group Inc (CME) Given Average Rating of “Buy” by Analysts

CME Group Inc (NASDAQ:CME) has earned a consensus recommendation of “Buy” from the sixteen brokerages that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $157.00.

Several equities analysts recently issued reports on the company. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Barclays upped their price objective on CME Group from $170.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, February 2nd. Bank of America upped their price objective on CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a research report on Friday, February 2nd. Sandler O’Neill reaffirmed a “buy” rating and issued a $175.00 price objective on shares of CME Group in a research report on Friday, February 2nd. Finally, Goldman Sachs Group raised CME Group from a “neutral” rating to a “buy” rating and set a $180.00 price objective on the stock in a research report on Wednesday, February 7th.

In other news, Director Jeffrey M. Bernacchi sold 1,501 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $149.75, for a total value of $224,774.75. Following the completion of the sale, the director now directly owns 60,194 shares in the company, valued at approximately $9,014,051.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Terrence A. Duffy sold 20,000 shares of the company’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $151.66, for a total value of $3,033,200.00. Following the completion of the sale, the chairman now owns 99,239 shares of the company’s stock, valued at $15,050,586.74. The disclosure for this sale can be found here. Insiders have sold a total of 67,128 shares of company stock worth $10,086,157 over the last three months. Insiders own 0.57% of the company’s stock.

Large investors have recently bought and sold shares of the company. ARK Investment Management LLC purchased a new stake in shares of CME Group in the 4th quarter worth $120,000. Valeo Financial Advisors LLC purchased a new stake in CME Group in the 3rd quarter worth $124,000. AlphaOne Investment Services LLC purchased a new stake in CME Group in the 4th quarter worth $146,000. Mosaic Family Wealth LLC purchased a new stake in CME Group in the 4th quarter worth $146,000. Finally, Truewealth LLC purchased a new stake in CME Group in the 4th quarter worth $157,000. Hedge funds and other institutional investors own 82.85% of the company’s stock.

CME Group (NASDAQ CME) traded up $0.03 during trading on Wednesday, hitting $160.16. The company had a trading volume of 1,238,300 shares, compared to its average volume of 1,659,618. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.03 and a quick ratio of 1.05. The stock has a market cap of $54,302.48, a P/E ratio of 13.41, a P/E/G ratio of 2.10 and a beta of 0.64. CME Group has a 52 week low of $114.82 and a 52 week high of $163.00.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The firm’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.14 EPS. research analysts predict that CME Group will post 6.26 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.75%. This is a boost from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s dividend payout ratio is presently 22.11%.

COPYRIGHT VIOLATION NOTICE: “CME Group Inc (CME) Given Average Rating of “Buy” by Analysts” was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/14/cme-group-inc-cme-given-average-rating-of-buy-by-analysts.html.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply